MAHMOOD K, THOMAS M, QU C; GECCO-CCFR CONSORTIUM; HSU L, BUCHANAN DD, PETERS U. Elucidating the Risk of Colorectal Cancer for Variants in Hereditary Colorectal Cancer Genes. Gastroenterology. 2023 Jul 14:S0016-5085(23)04770-4. doi: 10.1053/j.gastro.2023.06.032
ALEMANY-NAVARRO M, DIZ-DE ALMEIDA S, CRUZ R, et al. Psychiatric polygenic risk as a predictor of COVID-19 risk and severity: insight into the genetic overlap between schizophrenia and COVID-19. Transl Psychiatry. 2023 Jun 6;13(1):189. doi: 10.1038/s41398-023-02482-7
PAIRO-CASTINEIRA E, RAWLIK K, BRETHERICK AD, et al. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19. Nature. 2023 May;617(7962):764-768. doi: 10.1038/s41586-023-06034-3
YARMOLINSKY J, BOURAS E, CONSTANTINESCU A, et al. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis. Diabetologia. 2023 May 12. doi: 10.1007/s00125-023-05925-4
LINDSTRÖM S, WANG L, FENG H, et al. Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions. J Natl Cancer Inst. 2023 Jun 8;115(6):712-732. doi: 10.1093/jnci/djad043
BERMEJO-MARTIN JF, GARCÍA-MATEO N, MOTOS A, et al; CIBERES-UCI-COVID Group. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study. Lancet Microbe. 2023 Apr 25:S2666-5247(23)00041-1. doi: 10.1016/S2666-5247(23)00041-1.
NUNEZ-TORRES R, PITA G, PEÑA-CHILET M, et al. A Comprehensive Analysis of 21 Actionable Pharmacogenes in the Spanish Population: From Genetic Characterisation to Clinical Impact. Pharmaceutics. 2023 Apr 19;15(4):1286. doi: 10.3390/pharmaceutics15041286.
RODRÍGUEZ-GARCÍA C, RODRÍGUEZ-RUIZ E, RUANO-RAVIÑA A, et al. Is SARS-COV-2 associated with alpha-1 antitrypsin deficiency? J Thorac Dis. 2023 Feb 28;15(2):711-717. doi: 10.21037/jtd-22-1062
GONZÁLEZ LM, ROBLES NR, MOTA-ZAMORANO S, et al. Influence of variability in the cyclooxygenase pathway on cardiovascular outcomes of nephrosclerosis patients. Sci Rep. 2023 Jan 23;13(1):1253. doi: 10.1038/s41598-022-27343-z.
GARCÍA-GONZÁLEZ P, DE ROJAS I, MORENO-GRAU S, et al. Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer's Disease Aetiopathogenesis in Men. Int J Mol Sci. 2023 Jan 4;24(2):898. doi: 10.3390/ijms24020898
GARRIDO RUIZ PA, GONZÁLEZ-TABLAS M, PASCO PEÑA A, et al. Clinical, Histopathologic and Genetic Features of Rhabdoid Meningiomas. Int J Mol Sci. 2023 Jan 6;24(2):1116. doi: 10.3390/ijms24021116
GUZMÁN-JIMÉNEZ A, GONZÁLEZ-MUÑOZ S, CERVÁN-MARTÍN M, et al; IVIRMA Group; Lisbon Clinical Group. Contribution of TEX15 genetic variants to the risk of developing severe non-obstructive oligozoospermia. Front Cell Dev Biol. 2022 Dec 15;10:1089782. doi: 10.3389/fcell.2022.1089782
CRIADO I, NIETO WG, OLIVA-ARIZA G, et al, The Primary Health Care Group Of Salamanca For The Study Of Mbl. Age- and Sex-Matched Normal Leukocyte Subset Ranges in the General Population Defined with the EuroFlow Lymphocyte Screening Tube (LST) for Monoclonal B-Cell Lymphocytosis (MBL) vs. Non-MBL Subjects. Cancers (Basel). 2022 Dec 22;15(1):58. doi: 10.3390/cancers15010058
PRIETO-PEÑA D, GENRE F, PULITO-CUETO V, et al. Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway. Clin Exp Rheumatol. 2022 Dec 5. doi: 10.55563/clinexprheumatol/3cqh12
LU Y, ZHAO YC, CHANG-CLAUDE J, et al. Genetic Predictors for Fecal Propionate and Butyrate-Producing Microbiome Pathway are Not Associated with Colorectal Cancer Risk: A Mendelian Randomization Analysis. Cancer Epidemiol Biomarkers Prev. 2022 Dec 13:EPI-22-0861. doi: 10.1158/1055-9965
GARCÍA-FERNÁNDEZ C, LIZANO E, TELFORD M, et al. Y-chromosome target enrichment reveals rapid expansion of haplogroup R1b-DF27 in Iberia during the Bronze Age transition. Sci Rep. 2022 Dec 1;12(1):20708. doi: 10.1038/s41598-022-25200-7
OLIVA-ARIZA G, FUENTES-HERRERO B, CARBONELL C, et al. High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients. Blood. 2022 Nov 18:blood.2022017439. doi: 10.1182/blood.2022017439
CERVÁN-MARTÍN M, TÜTTELMANN F, LOPES AM, et alD. Immune and spermatogenesis-related loci are involved in the development of extreme patterns of male infertility. Commun Biol. 2022 Nov 10;5(1):1220. doi: 10.1038/s42003-022-04192-0
PMID: 36233442
FERREIRA LC, GOMES CEM, RODRIGUES-NETO JF, JERONIMO SMB. Genome-wide association studies of COVID-19: Connecting the dots. Infect Genet Evol. 2022 Oct 21;106:105379. doi: 10.1016/j.meegid.2022.105379
BATISTA LIZ JC, GENRE F, PULITO-CUETO V, et al. IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms. J Clin Med. 2022 Sep 22;11(19):5577. doi: 10.3390/jcm11195577
MARTÍNEZ-LÓPEZ J, KERICK M, ORTIZ-FERNÁNDEZ L, et al. FLT3 functional low-frequency variant rs76428106-C is associated with susceptibility to systemic sclerosis. Rheumatology (Oxford). 2022 Jul 25:keac406. doi: 10.1093/rheumatology/keac406
GONZÁLEZ-CASIMIRO CM, ARRIBAS-RODRÍGUEZ E, FIZ-LÓPEZ A, et al. Altered Surface Expression of Insulin-Degrading Enzyme on Monocytes and Lymphocytes from COVID-19 Patients Both at Diagnosis and after Hospital Discharge. Int J Mol Sci. 2022 Sep 21;23(19):11070. doi: 10.3390/ijms231911070.
FERNÁNDEZ CRESPO S, PÉREZ-MATUTE P, ÍÑIGUEZ MARTÍNEZ M, et al. Gravedad de COVID-19 atribuible a obesidad según IMC y CUN-BAE [Severity of COVID-19 attributable to obesity according to BMI and CUN-BAE]. Semergen. 2022 Sep 13;48(8):101840. Spanish. doi: 10.1016/j.semerg.2022.101840.
PÉREZ-OLIVEIRA S, ÁLVAREZ I, ROSAS I, et al. Intermediate and Expanded HTT Alleles and the Risk for α-Synucleinopathies. Mov Disord. 2022 Sep;37(9):1841-1849. doi: 10.1002/mds.29153.
CERVÁN-MARTÍN M, BOSSINI-CASTILLO L, GUZMÁN-JIMÉNEZ A, et al. Common genetic variation in KATNAL1 non-coding regions is involved in the susceptibility to severe phenotypes of male infertility. Andrology. 2022 Oct;10(7):1339-1350. doi: 10.1111/andr.13221.